Kissei Pharmaceutical Co., Ltd.
4547.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | ¥11,961 | ¥11,161 | ¥13,680 | ¥16,507 |
| Dep. & Amort. | ¥4,615 | ¥4,254 | ¥4,109 | ¥3,730 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | -¥668 | -¥9,296 | -¥5,500 | ¥116 |
| Other Non-Cash | -¥9,387 | -¥7,796 | -¥18,968 | -¥18,820 |
| Operating Cash Flow | ¥6,521 | -¥1,677 | -¥6,679 | ¥1,533 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥8,565 | -¥1,201 | -¥2,547 | -¥1,919 |
| Net Acquisitions | ¥519 | ¥175 | -¥363 | -¥385 |
| Inv. Purchases | -¥978 | -¥2,400 | -¥1,866 | -¥5,757 |
| Inv. Sales/Matur. | ¥14,069 | ¥14,813 | ¥14,985 | ¥22,245 |
| Other Inv. Act. | -¥93 | -¥2,697 | -¥4,208 | -¥3,408 |
| Investing Cash Flow | ¥4,952 | ¥8,690 | ¥6,001 | ¥10,776 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥230 | -¥150 | -¥150 | -¥103 |
| Stock Issued | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock Repurch. | -¥5,293 | -¥6,000 | ¥0 | ¥0 |
| Dividends Paid | -¥3,801 | -¥3,722 | -¥3,135 | -¥2,536 |
| Other Fin. Act. | -¥1 | -¥134 | -¥135 | -¥117 |
| Financing Cash Flow | -¥9,325 | -¥10,006 | -¥3,420 | -¥2,756 |
| Forex Effect | ¥27 | -¥3 | -¥21 | ¥4 |
| Net Chg. in Cash | ¥2,271 | -¥2,997 | -¥4,120 | ¥9,557 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥45,887 | ¥48,884 | ¥53,004 | ¥43,447 |
| End Cash | ¥48,158 | ¥45,887 | ¥48,884 | ¥53,004 |
| Free Cash Flow | ¥2,014 | -¥3,510 | -¥9,226 | -¥386 |